ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

Market Cap	16.33B -45.8%
Revenue (ttm)	940.78M -21.9%
Net Income	199.99M
EPS	0.44
Shares Out	448.53M
PE Ratio	82.22
Forward PE	31.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,571,224
Open	40.77
Previous Close	36.40
Day's Range	33.50 - 40.77
52-Week Range	29.31 - 81.48
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHE:300723

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services. The company was formerly known as ApicHope Pharmaceutical C...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 1,294
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300723

Financial Performance

In 2025, SHE:300723's revenue was 932.27 million, a decrease of -35.72% compared to the previous year's 1.45 billion. Losses were -337.79 million, -37.45% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 21, 2026

Data Sources Report a data error